相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。TGF-β orchestrates the phenotype and function of monocytic myeloid-derived suppressor cells in colorectal cancer
Luciana Gneo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2022)
CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer
Yuanyi Yue et al.
FRONTIERS IN IMMUNOLOGY (2022)
Ketogenesis Attenuates KLF5-Dependent Production of CXCL12 to Overcome the Immunosuppressive Tumor Microenvironment in Colorectal Cancer
Ruozheng Wei et al.
CANCER RESEARCH (2022)
Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies
Md Sanower Hossain et al.
CANCERS (2022)
Comparison of Immune Response Assessment in Colon Cancer by Immunoscore (Automated Digital Pathology) and Pathologist Visual Scoring
Isabelle Boquet et al.
CANCERS (2022)
PU.1-driven Th9 Cells Promote Colorectal Cancer in Experimental Colitis Models Through Il-6 Effects in Intestinal Epithelial Cells
Katharina Gerlach et al.
JOURNAL OF CROHNS & COLITIS (2022)
Blockade of IL-6 inhibits tumor immune evasion and improves anti-PD-1 immunotherapy
Wenyi Li et al.
CYTOKINE (2022)
Remodeling the tumor microenvironment via blockade of LAIR-1 and TGF-β signaling enables PD-L1-mediated tumor eradication
Lucas A. Horn et al.
JOURNAL OF CLINICAL INVESTIGATION (2022)
Histone methyltransferase WHSC1 loss dampens MHC-I antigen presentation pathway to impair IFN-γ stimulated antitumor immunity
Jiale Ren et al.
JOURNAL OF CLINICAL INVESTIGATION (2022)
Utilizing chemokines in cancer immunotherapy
Florian Markl et al.
TRENDS IN CANCER (2022)
VEGFR2-targeted antibody fused with IFNαmut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity
Pengzhao Shang et al.
ACTA PHARMACEUTICA SINICA B (2021)
Cell Therapy for Colorectal Cancer: The Promise of Chimeric Antigen Receptor (CAR)-T Cells
Cristina Aparicio et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer
Carmine Stolfi et al.
BIOMOLECULES (2021)
Prognostic Immune-Related Analysis Based on Differentially Expressed Genes in Left- and Right-Sided Colon Adenocarcinoma
Jun-Nan Guo et al.
FRONTIERS IN ONCOLOGY (2021)
Inflammatory Mediators and Gut Microbial Toxins Drive Colon Tumorigenesis by IL-23 Dependent Mechanism
Janani Panneerselvam et al.
CANCERS (2021)
Poly(I:C) enhances the efficacy of phagocytosis checkpoint blockade immunotherapy by inducing IL-6 production
Cheng Zhong et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2021)
Targeting Immune Cell Trafficking - Insights From Research Models and Implications for Future IBD Therapy
Maximilian Wiendl et al.
FRONTIERS IN IMMUNOLOGY (2021)
Clinical Significance of Chemokine Receptor CXCR4 and CCR7 mRNA Expression in Patients With Colorectal Cancer
Shinsuke Nagasawa et al.
ANTICANCER RESEARCH (2021)
Tumor promoting capacity of polymorphonuclear myeloid-derived suppressor cells and their neutralization
Christopher Groth et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Association of gene and protein expression and genetic polymorphism of CC chemokine ligand 4 in colorectal cancer
Levar Shamoun et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
Integrin β7 Inhibits Colorectal Cancer Pathogenesis via Maintaining Antitumor Immunity
Youhua Zhang et al.
CANCER IMMUNOLOGY RESEARCH (2021)
IL-35 Regulates the Function of Immune Cells in Tumor Microenvironment
Kewei Liu et al.
FRONTIERS IN IMMUNOLOGY (2021)
Emerging Complexity in CD4+T Lineage Programming and Its Implications in Colorectal Cancer
Daniel DiToro et al.
FRONTIERS IN IMMUNOLOGY (2021)
CXCR6 is required for antitumor efficacy of intratumoral CD8+ T cell
Binglin Wang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Lead Time and Prognostic Role of Serum CEA, CA19-9, IL-6, CRP, and YKL-40 after Adjuvant Chemotherapy in Colorectal Cancer
Kaisa Lehtomaki et al.
CANCERS (2021)
The Relationship between Inflammation Markers (CRP, IL-6, sCD40L) and Colorectal Cancer Stage, Grade, Size and Location
Olga Martyna Koper-Lenkiewicz et al.
DIAGNOSTICS (2021)
The inflammatory pathogenesis of colorectal cancer
Mark Schmitt et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Colon cancer and immunotherapy-can we go beyond microsatellite instability?
Rimini Breakstone
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
PD-L1 expression increased by IFN-γ via JAK2-STAT1 signaling and predicts a poor survival in colorectal cancer
Tiancheng Zhao et al.
ONCOLOGY LETTERS (2020)
TGF-β signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancer
Laura Garcia Perez et al.
NATURE COMMUNICATIONS (2020)
CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond
Nathan Karin
FRONTIERS IN IMMUNOLOGY (2020)
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
G. Argiles et al.
ANNALS OF ONCOLOGY (2020)
CX3CR1-CD8+ T cells are critical in antitumor efficacy but functionally suppressed in the tumor microenvironment
Takayoshi Yamauchi et al.
JCI INSIGHT (2020)
Th17 cells inhibit CD8+ T cell migration by systematically downregulating CXCR3 expression via IL-17A/STAT3 in advanced-stage colorectal cancer patients
Dan Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Tumor inhibition or tumor promotion? The duplicity of CXCR3 in cancer
Eleonora Russo et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2020)
Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor Microenvironment
Susannah L. Hewitt et al.
CLINICAL CANCER RESEARCH (2020)
Resolving the Paradox of Colon Cancer Through the Integration of Genetics, Immunology, and the Microbiota
Marine Fidelle et al.
FRONTIERS IN IMMUNOLOGY (2020)
The Role of Interleukins in Colorectal Cancer
Jingjing Li et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Surgical trauma-induced CCL18 promotes recruitment of regulatory T cells and colon cancer progression
Zhirong Sun et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Non-platelet-derived CXCL4 differentially regulates cytotoxic and regulatory T cells through CXCR3 to suppress the immune response to colon cancer
Shaorong Deng et al.
CANCER LETTERS (2019)
Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion
Deepali Sawant et al.
NATURE IMMUNOLOGY (2019)
Intrinsic β-catenin signaling suppresses CD8+ T-cell infiltration in colorectal cancer
Junli Xue et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Cancer treatment and survivorship statistics, 2019
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
IFN-γ: A cytokine at the right time, is in the right place
J. Daniel Burke et al.
SEMINARS IN IMMUNOLOGY (2019)
Significantly increased anti-tumor activity of carcinoembryonic antigen-specific chimeric antigen receptor T cells in combination with recombinant human IL-12
Xiaowei Chi et al.
CANCER MEDICINE (2019)
The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment
Nathan Reynders et al.
CELLS (2019)
Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling
Dan Wang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
IL-23 in inflammatory bowel diseases and colon cancer
Markus F. Neurath
CYTOKINE & GROWTH FACTOR REVIEWS (2019)
Reprogramming the murine colon cancer microenvironment using lentivectors encoding shRNA against IL-10 as a component of a potent DC-based chemoimmunotherapy
Joanna Rossowska et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
Daniele V. F. Tauriello et al.
NATURE (2018)
Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models (vol 13, e019168, 2018)
Folashade Otegbeye et al.
PLOS ONE (2018)
Obesity exacerbates colitis-associated cancer via IL-6-regulated macrophage polarisation and CCL-20/CCR-6-mediated lymphocyte recruitment
Claudia M. Wunderlich et al.
NATURE COMMUNICATIONS (2018)
Differential role of CXCR3 in inflammation and colorectal cancer
Jessicca D. Abron et al.
Oncotarget (2018)
β7 integrins contribute to intestinal tumor growth in mice
Srustidhar Das et al.
PLOS ONE (2018)
Targeting Interleukin-6 (IL-6) Sensitizes Anti-PD-L1 Treatment in a Colorectal Cancer Preclinical Model
Jibin Li et al.
MEDICAL SCIENCE MONITOR (2018)
Roles for Interleukin 17 and Adaptive Immunity in Pathogenesis of Colorectal Cancer
Christopher G. Hurtado et al.
GASTROENTEROLOGY (2018)
Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer
F. Amicarella et al.
GUT (2017)
Role of chemokine receptors and intestinal epithelial cells in the mucosal inflammation and tolerance
Neeraja Kulkarni et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2017)
The effect of CT26 tumor-derived TGF-β on the balance of tumor growth and immunity
Stephanie Y. Owyang et al.
IMMUNOLOGY LETTERS (2017)
Modified nanoparticle mediated IL-12 immunogene therapy for colon cancer
Xiaoxiao Liu et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
Interferon-inducible CXC-chemokines are crucial immune modulators and survival predictors in colorectal cancer
Larissa Kistner et al.
ONCOTARGET (2017)
Molecular Signatures of Human Regulatory T Cells in Colorectal Cancer and Polyps
Nor Adzimah Johdi et al.
FRONTIERS IN IMMUNOLOGY (2017)
Defective IL-23/IL-17 Axis Protects p47phox-/-Mice from Colon Cancer
Cornelia Richter et al.
Frontiers in Immunology (2017)
Anti-Adhesion Therapies in inflammatory Bowel Disease-Molecular and Clinical Aspects
Sebastian Zundler et al.
FRONTIERS IN IMMUNOLOGY (2017)
Anti-VEGFR2-interferon-α2 regulates the tumor microenvironment and exhibits potent antitumor efficacy against colorectal cancer
Zhaoting Li et al.
ONCOIMMUNOLOGY (2017)
Lack of interleukin-6 in the tumor microenvironment augments type-1 immunity and increases the efficacy of cancer immunotherapy
Yosuke Ohno et al.
CANCER SCIENCE (2017)
IL-6 as a keystone cytokine in health and disease (vol 16, pg 448, 2015)
Christopher A. Hunter et al.
NATURE IMMUNOLOGY (2017)
Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor Microenvironment
Kanstantsin V. Katlinski et al.
CANCER CELL (2017)
Batf-dependent Th17 cells critically regulate IL-23 driven colitis-associated colon cancer
Elise Punkenburg et al.
GUT (2016)
Tissue-infiltrating neutrophils represent the main source of IL-23 in the colon of patients with IBD
Egle Kvedaraite et al.
GUT (2016)
The Fractalkine-Receptor Axis Improves Human Colorectal Cancer Prognosis by Limiting Tumor Metastatic Dissemination
Marco Erreni et al.
JOURNAL OF IMMUNOLOGY (2016)
Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients
Niels Halama et al.
CANCER CELL (2016)
Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers
Takuro Saito et al.
NATURE MEDICINE (2016)
Feedback mechanisms between M2 macrophages and Th17 cells in colorectal cancer patients
Hui Mao et al.
TUMOR BIOLOGY (2016)
modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient
Imran Siddiqui et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
The infiltration, and prognostic importance, of Th1 lymphocytes vary in molecular subgroups of colorectal cancer
Agnes Ling et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2016)
Generation of Tumor-Specific Cytotoxic T-Lymphocytes from the Peripheral Blood of Colorectal Cancer Patients for Adoptive T-Cell Transfer
Silvia Carluccio et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2015)
Deficiency of Interferon-Gamma or Its Receptor Promotes Colorectal Cancer Development
Lu Wang et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2015)
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Stefani Spranger et al.
NATURE (2015)
Stromal gene expression defines poor-prognosis subtypes in colorectal cancer
Alexandre Calon et al.
NATURE GENETICS (2015)
Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with GranzymeB+ CD8+ T-cell infiltration
Timothy J. Zumwalt et al.
ONCOTARGET (2015)
The effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer
S. T. Ward et al.
BRITISH JOURNAL OF CANCER (2015)
Upregulation of TLRs and IL-6 as a Marker in Human Colorectal Cancer
Chien-Chang Lu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
NK cell inflammation in the clinical outcome of colorectal carcinoma
Andrea Coppola et al.
FRONTIERS IN MEDICINE (2015)
Smad7 induces plasticity in tumor-infiltrating Th17 cells and enables TNF-alpha-mediated killing of colorectal cancer cells
Angelamaria Rizzo et al.
CARCINOGENESIS (2014)
γδT17 Cells Promote the Accumulation and Expansion of Myeloid-Derived Suppressor Cells in Human Colorectal Cancer
Pin Wu et al.
IMMUNITY (2014)
Crucial involvement of the CCL3-CCR5 axis-mediated fibroblast accumulation in colitis-associated carcinogenesis in mice
Soichiro Sasaki et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Immune Escape Mechanisms in Colorectal Cancer Pathogenesis and Liver Metastasis
Massimo Pancione et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Control of the immune response by pro-angiogenic factors
Thibault Voron et al.
FRONTIERS IN ONCOLOGY (2014)
VEGFA-VEGFR Pathway Blockade Inhibits Tumor-Induced Regulatory T-cell Proliferation in Colorectal Cancer
Magali Terme et al.
CANCER RESEARCH (2013)
Eradication of Liver-Implanted Tumors by Semliki Forest Virus Expressing IL-12 Requires Efficient Long-Term Immune Responses
Jose I. Quetglas et al.
JOURNAL OF IMMUNOLOGY (2013)
Tumor-Derived IL-35 Promotes Tumor Growth by Enhancing Myeloid Cell Accumulation and Angiogenesis
Zhihui Wang et al.
JOURNAL OF IMMUNOLOGY (2013)
Chemokine CXCL16 suppresses liver metastasis of colorectal cancer via augmentation of tumor-infiltrating natural killer T cells in a murine model
Ji-Ye Kee et al.
ONCOLOGY REPORTS (2013)
Role of TH17 cytokines in the control of colorectal cancer
Veronica De Simone et al.
ONCOIMMUNOLOGY (2013)
CD14+S100A9+ Monocytic Myeloid-derived Suppressor Cells and Their Clinical Relevance in Non-Small Cell Lung Cancer
Po-Hao Feng et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
The prognostic significance of chemokine receptor CXCR3 expression in colorectal carcinoma
Zhenqian Wu et al.
BIOMEDICINE & PHARMACOTHERAPY (2012)
Increased intratumoral IL-22-producing CD4+ T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival
Yuan Zhuang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Tumor-Derived Chemokine CCL5 Enhances TGF-β-Mediated Killing of CD8+ T Cells in Colon Cancer by T-Regulatory Cells
Li-Yuan Chang et al.
CANCER RESEARCH (2012)
Anticancer Properties of the IL-12 Family - Focus on Colorectal Cancer
M. A. Engel et al.
CURRENT MEDICINAL CHEMISTRY (2012)
A Variant of Smurf2 Protects Mice Against Colitis-Associated Colon Cancer by Inducing Transforming Growth Factor β Signaling
Heike Dornhoff et al.
GASTROENTEROLOGY (2012)
Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth
Sergei I. Grivennikov et al.
NATURE (2012)
IL-12 family cytokines: immunological playmakers
Dario A. A. Vignali et al.
NATURE IMMUNOLOGY (2012)
IL-17A in the tumor microenvironment of the human colorectal adenoma-carcinoma sequence
Guanglin Cui et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
CXCR6: The Role of Environment in Tumor Progression. Challenges for Therapy
Caterina A. M. La Porta
STEM CELL REVIEWS AND REPORTS (2012)
IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer
Markus F. Neurath et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2011)
IL-23/IL-23R: potential mediator of intestinal tumor progression from adenomatous polyps to colorectal carcinoma
Feng Lan et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2011)
Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy
Pravin Mishra et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
Reversal of gastrointestinal carcinoma-induced immunosuppression and induction of antitumoural immunity by a combination of cyclophosphamide and gene transfer of IL-12
Mariana Malvicini et al.
MOLECULAR ONCOLOGY (2011)
Tumor-Associated Macrophages Recruit CCR6+ Regulatory T Cells and Promote the Development of Colorectal Cancer via Enhancing CCL20 Production in Mice
Jinlin Liu et al.
PLOS ONE (2011)
Natural killer cell is a major producer of interferon γ that is critical for the IL-12-induced anti-tumor effect in mice
Akio Uemura et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Biomolecular Network Reconstruction Identifies T-Cell Homing Factors Associated With Survival in Colorectal Cancer
Bernhard Mlecnik et al.
GASTROENTEROLOGY (2010)
Low expression of chemokine receptor CCR5 in human colorectal cancer correlates with lymphatic dissemination and reduced CD8(+) T-cell infiltration
Tim Zimmermann et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2010)
Transcriptional regulation of the mucosal immune system mediated by T-bet
N. Powell et al.
MUCOSAL IMMUNOLOGY (2010)
The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo
Mandy J. McGeachy et al.
NATURE IMMUNOLOGY (2009)
The specific immune response to tumor antigen CP1 and its correlation with improved survival in colon cancer patients
Fang-Fang Liu et al.
GASTROENTEROLOGY (2008)
The T-box transcription factor eomesodermin controls CD8 T cell activity and lymph node metastasis in human colorectal cancer
Imke Atreya et al.
GUT (2007)
IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways
Liang Zhou et al.
NATURE IMMUNOLOGY (2007)
Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes
K. Kawada et al.
ONCOGENE (2007)
High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer
Shozo Hojo et al.
CANCER RESEARCH (2007)
Review article: immune suppression and colorectal cancer
C. Evans et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Transforming growth factor β induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis
MC Fantini et al.
GUT (2006)
Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer
P Ghadjar et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
TGF-beta as a T cell regulator in colitis and colon cancer
C Becker et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
Effector memory T cells, early metastasis, and survival in colorectal cancer
F Pagès et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27
N Morishima et al.
JOURNAL OF IMMUNOLOGY (2005)
Semliki forest virus vectors engineered to express higher IL-12 levels induce efficient elimination of murine colon adenocarcinomas
JR Rodriguez-Madoz et al.
MOLECULAR THERAPY (2005)
Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals
M Chiyo et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice
SE Erdman et al.
CANCER RESEARCH (2005)
Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival
J Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
MIP-1α and MIP-1β differentially mediate mucosal and systemic adaptive immunity
JW Lillard et al.
BLOOD (2003)
Macrophage inflammatory protein-1
P Menten et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery
G Galizia et al.
CLINICAL IMMUNOLOGY (2002)
Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status
JM Michael-Robinson et al.
GUT (2001)
IL-12 gene therapy of leukemia with hematopoietic progenitor cells without the toxicity of systemic IL-12 treatment
YX Xu et al.
CLINICAL IMMUNOLOGY (2001)